Tune Therapeutics
Christina Lee currently serves as a Senior Research Associate at Tune Therapeutics as of October 2023. Previously, Christina held roles including Senior Laboratory Technician at xilis and Senior Research Associate at StrideBio, Inc., where responsibilities included leading in vivo studies, analyzing biodistribution and gene expression, and mentoring laboratory staff. Christina's extensive research experience also includes positions at Virginia Commonwealth University, where Christina investigated therapeutic agents in prostate cancer and implemented new laboratory techniques, and Boise State University, where Christina focused on antibiotics research. Christina earned a Master of Science in Pharmacology and Toxicology from Virginia Commonwealth University and a Bachelor of Science in Chemistry from Boise State University.
Tune Therapeutics
1 followers
With its versatile and powerful TEMPO epigenomic control platform, Tune Therapeutics is pioneering a new therapeutic modality that can fine-tune any gene network and unlock the full power and potential of regenerative medicine. With deep experience and a passionate commitment to exploration and innovation, Tune is driving through an inflection point in the history of genetic medicine: from targeting a limited range of rare conditions, to addressing thousands of common and complex diseases for which no curative treatment is available.